High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma

Experimental and Therapeutic Medicine

Volumn 1, Issue 5, 2010, Pages 893-898

  Shen, Cheng Huang ^a,b   Hsieh, Hsiao Yen ^a   Wang, Yuan Hung ^c,d   Chen, Syue Yi ^a   Tung, Chun Liang ^a   Wu, Jiann Der ^a   Lin, Chang TeLin ^a   Chan, Michael W Y ^b   Hsu, Cheng Da ^a,b   Chang, Deching ^b  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Dickkopf 1; Disease free survival; Urothelial carcinoma

Indexed keywords

DICKKOPF 1 PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UROGENITAL TRACT TUMOR; WESTERN BLOTTING;

EID: 77955224591     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.134     Document Type: Article

References (32)

1. Arrizabalaga M, Navarro J, Mora M, Castro M, Extramiana J, Manas A, Diez J and Paniagua P: [Transitional carcinomas of the urinary tract: synchronous and metachronous lesions]. Actas Urol Esp 18: 782-796, 1994.
2. Shen CH, Wang YH, Wang WC, Jou YC, Hsu HS, Hsieh HY and Chiou HY: Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk. Urology 69: 1001-1006, 2007.
3. Herr HW: Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J Urol 15: 84-88, 1997.
4. Pashos CL, Botteman MF, Laskin BL and Redaelli A: Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract 10: 311-322, 2002.
5. Morey SS: American Urological Association issues guidelines on the management of bladder cancer. Am Fam Physician 61: 3734-3736, 2000.
6. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, EspadaJ, Garcia JM, Munoz A, Esteller M and Gonzalez-SanchoJM: Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25: 4116-4121, 2006.
7. Forget MA, Turcotte S, Beauseigle D, Godin-Ethier J, Pelletier S, Martin J, Tanguay S and Lapointe R: The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96: 646-653, 2007.
8. Jiang T, Wang S, Huang L and Zhang S: Clinical significance of serum DKK-1 in patients with gynecological cancer. Int J Gynecol Cancer 19: 1177-1181, 2009.
9. Patil MA, Chua MS, Pan KH, Lin R, Lih CJ, Cheung ST, HoC, Li R, Fan ST, Cohen SN, Chen X and So S: An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 24: 3737-3747, 2005.
10. Yamabuki T, Takano A, Hayama S, Ishikawa N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, Fujita M, Hosokawa M, Tsuchiya E, Kohno N, Kondo S, Nakamura Y and Daigo Y: Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67: 2517-2525, 2007.
11. Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, SuzukiY, Sugano S and Akiyama T: DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23: 8520-8526, 2004.
12. Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, Garcia de Herreros A, Bonilla F and Munoz A: The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 24: 1098-1103, 2005.
13. Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T and Cairns P: Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res 10: 1887-1893, 2004.
14. Kastritis E, Murray S, Kyriakou F, Horti M, Tamvakis N, Kavantzas N, Patsouris ES, Noni A, Legaki S, Dimopoulos MA and Bamias A: Somatic mutations of adenomatous polyposis coli gene and nuclear b-catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway implication. Int J Cancer 124: 103-108, 2009.
15. Marsit CJ, Karagas MR, andrew A, Liu M, Danaee H, SchnedAR, Nelson HH and Kelsey KT: Epigenetic inactivation of SFRPgenes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 65: 7081-7085, 2005.
16. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B and Gazdar AF: Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61: 8659-8663, 2001.
17. Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C and Hartmann A: Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest 84: 465-478, 2004.
18. Urakami S, Shiina H, Enokida H, Kawakami T, KawamotoK, HirataH, Tanaka Y, Kikuno N, Nakagawa M, Igawa M and DahiyaR: Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 12: 2109-2116, 2006.
19. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, KonetyBR, Igawa M and Dahiya R: Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res 12: 383-391, 2006.
20. Kakiuchi S, Daigo Y, Ishikawa N, Furukawa C, Tsunoda T, YanoS, Nakagawa K, Tsuruo T, Kohno N, Fukuoka M, Sone S and Nakamura Y: Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet 13: 3029-3043, 2004.
21. Kakiuchi S, Daigo Y, Tsunoda T, Yano S, Sone S and NakamuraY: Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 1: 485-499, 2003.
22. Kikuchi T, Daigo Y, Ishikawa N, Katagiri T, Tsunoda T, YoshidaS and Nakamura Y: Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNAmicroarray. Int J Oncol 28: 799-805, 2006.
23. Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, KakiuchiS, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi K, Imai K and Nakamura Y: Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22: 2192-2205, 2003.
24. Taniwaki M, Daigo Y, Ishikawa N, Takano A, Tsunoda T, YasuiW, Inai K, Kohno N and Nakamura Y: Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol 29: 567-575, 2006.
25. Yamabuki T, Daigo Y, Kato T, Hayama S, Tsunoda T, MiyamotoM, Ito T, Fujita M, Hosokawa M, Kondo S and Nakamura Y: Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas. Int J Oncol 28: 1375-1384, 2006.
26. Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701, 2004.
27. Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature 434: 843-850, 2005.
28. Aman A and Piotrowski T: Wnt/beta-catenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression. Dev Cell 15: 749-761, 2008.
29. Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR and Varmus HE: FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBOJ 24: 73-84, 2005.
30. Politou MC, Heath DJ, Rahemtulla A, Szydlo R, AnagnostopoulosA, Dimopoulos MA, Croucher PI and TerposE: Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation. Int J Cancer 119: 1728-1731, 2006.
31. Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J, Fan J and Qin W: Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol 50: 948-957, 2009.
32. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D and Skinner DG: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666-675, 2001